ANTX
AN2 Therapeutics, Inc.NASDAQHealthcare$3.27+3.06%ClosedMarket Cap: $89.6M
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
19
Sales
10
Buy/Sell Ratio
1.90
Total Bought
$0.00
Total Sold
$9.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 82,300 | $3.91 | 82,300 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 73,665 | $3.91 | 73,665 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 66,000 | $3.91 | 66,000 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 73,665 | $6.60 | 0 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 66,000 | $17.28 | 0 |
| Mon Mar 23 | Day Lucy | officer: Chief Financial Officer | Sell | 82,300 | $14.29 | 0 |
| Mon Mar 23 | Chanda Sanjay | officer: Chief Development Officer | Sell | 66,000 | $3.91 | 66,000 |
| Mon Mar 23 | Chanda Sanjay | officer: Chief Development Officer | Sell | 57,950 | $3.91 | 57,950 |
| Mon Mar 23 | Chanda Sanjay | officer: Chief Development Officer | Sell | 41,665 | $3.91 | 41,665 |
| Mon Mar 23 | Chanda Sanjay | officer: Chief Development Officer | Sell | 66,000 | $17.28 | 0 |